A cheap FTSE 250 share I think could fly during the Santa Rally!

The FTSE 250 has historically delivered its best results during December. Value shares like this one could be in prime position to soar.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Snowing on Jubilee Gardens in London at dusk

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

UK share prices are soaring, sparking speculation that a Santa Rally might be underway. The FTSE 100 is up 1% so far in December. The FTSE 250 meanwhile, has risen by around half a percentage point.

The FTSE 100 is the best-performing major index (bar the Hang Seng) in December, history shows us. But if the past is any guide, the FTSE 250 could significantly outperform its bigger brother this month.

Strong returns

Since its inception in the mid-80s, the Footsie has provided an average December return of 2.29%. That’s according to fresh research from broker eToro.

That’s a pretty decent return, in my view. However, it’s some distance below the average 2.71% return that FTSE 250 shares have provided in Decembers gone by. This 2.71% end-of-year return’s also better than the 2.19% average return typically delivered between January and November.

Room for a bull run?

Given the cheapness of FTSE 250 shares today, I think there’s plenty of scope for the index to rise strongly this particular December.

Today, the price-to-earnings (P/E) ratio on FTSE 250 shares stands at 14.2 times. This is well below the historical average of 22-23 times. And it suggests the index might be packed with brilliant bargains to buy.

I can try to capitalise on this by purchasing an index tracking fund such as the HSBC FTSE 250 ETF. This particular tracker’s delivered an average annual return of 8.5% since spring 2004. It could provide even better returns too, if the index plays catch-up following recent underperformance.

However, I could get better returns by purchasing individual shares. This is higher risk than spreading my capital across the entire index. But the potential for smashing profits may make this worthwhile.

A top FTSE 250 stock

With this in mind, I’m considering adding to my existing position in brickmaker Ibstock (LSE:IBST). I think it looks too cheap to miss, based on predicted earnings for 2025.

At 186p per share, the company trades on a forward P/E ratio of 16.9 times. To put this in context, its P/E has averaged 21.7 times during the last five years.

On top of this, Ibstock shares change hands on a price-to-earnings growth (PEG) multiple of just 0.4. Any reading below 1 implies that a stock is undervalued.

City brokers think the brickmaker’s earnings will soar 22% in 2025 as housebuilding activity gets back to normal. A stream of positive market data supports these forecasts, with latest Nationwide data showing average house prices rose at their quickest since November 2022 last month, at 3.7%.

Of course broker estimates don’t guarantee what will happen. Ibstock’s sales — which dropped 20% in the six months to June — could disappoint if interest rates remain around current highs, dampening demand for new-build homes.

However, I believe this possibility is reflected in the company’s low valuation. Given the housing market’s strong improvement, I think its shares have a chance of rising this December.

Royston Wild has positions in Ibstock Plc. The Motley Fool UK has recommended Ibstock Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Close-up of British bank notes
Investing Articles

£20,000 for a Stocks and Shares ISA? Here’s how to try and turn it into a monthly passive income of £493

Hundreds of pounds in passive income a month from a £20k Stocks and Shares ISA? Here's how that might work…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

£5,000 put into Nvidia stock last Christmas is already worth this much!

A year ago, Nvidia stock was already riding high -- but it's gained value since. Our writer explores why and…

Read more »

Investing Articles

Are Tesco shares easy money heading into 2026?

The supermarket industry is known for low margins and intense competition. But analysts are bullish on Tesco shares – and…

Read more »

Smiling black woman showing e-ticket on smartphone to white male attendant at airport
Investing Articles

Can this airline stock beat the FTSE 100 again in 2026?

After outperforming the FTSE 100 in 2025, International Consolidated Airlines Group has a promising plan to make its business more…

Read more »

Investing Articles

1 Stocks and Shares ISA mistake that will make me a better investor in 2026

All investors make mistakes. The best ones learn from them. That’s Stephen Wright’s plan to maximise returns from his Stocks…

Read more »

Portrait Of Senior Couple Climbing Hill On Hike Through Countryside In Lake District UK Together
Investing Articles

I asked ChatGPT if £20,000 would work harder in an ISA or SIPP in 2026 and it said…

Investors have two tax-efficient ways to build wealth, either in a Stocks and Shares ISA or SIPP. Harvey Jones asked…

Read more »

Investing Articles

How much would I need invested in an ISA to earn £2,417 a month in passive income?

This writer runs the numbers to see what it takes in an ISA to reach £2,417 a month in passive…

Read more »

Investing Articles

Rolls-Royce shares or Melrose Industries: Which one is better value for 2026?

Rolls-Royce shares surged in 2025, surpassing most expectations. Dr James Fox considers whether it offers better value than peer Melrose.

Read more »